Comparative Pharmacology
Head-to-head clinical analysis: CHLORAPREP TRIPLE SWABSTICK versus PHISO SCRUB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLORAPREP TRIPLE SWABSTICK versus PHISO SCRUB.
CHLORAPREP TRIPLE SWABSTICK vs PHISO-SCRUB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate and isopropyl alcohol act as antiseptics. Chlorhexidine disrupts bacterial cell membranes and precipitates cytoplasmic contents, while isopropyl alcohol denatures proteins and dissolves lipids, leading to rapid microbial death.
Phiso-Scrub is a topical antiseptic containing triclosan, which inhibits bacterial fatty acid synthesis by targeting enoyl-acyl carrier protein reductase (FabI), leading to disruption of cell membrane integrity and bacterial cell death.
Apply topically to intact skin for 30 seconds and allow to dry for at least 3 minutes. Dosage is based on area of skin to be disinfected; typically one swabstick per site.
Topical application to affected area once daily; chlorhexidine gluconate 4% scrub, lather for 3-5 minutes, rinse thoroughly.
None Documented
None Documented
Chlorhexidine gluconate: Terminal elimination half-life is approximately 1.1 hours for the absorbed fraction in plasma after topical application; however, the drug persists at the application site with substantive activity for up to 6 hours. Alcohol evaporates rapidly; half-life of isopropyl alcohol in blood is <1 hour.
Approximately 8-12 hours in patients with normal renal function (CrCl >90 mL/min). Half-life is significantly prolonged in renal impairment (up to 40 hours in ESRD).
Chlorhexidine gluconate is primarily excreted unchanged in feces (≥90%) after oral administration; negligible renal excretion (<1%). Isopropyl alcohol and the orange dye are metabolized or exhaled. For topical application, systemic absorption is minimal (<1%), and absorbed drug is excreted predominantly via feces (biliary).
Primarily renal excretion of unchanged drug (approximately 70-80% of absorbed dose). Biliary/fecal elimination accounts for the remainder (20-30%).
Category C
Category C
Antiseptic
Antiseptic